Absorption kinetics after inhalation of fluticasone propionate via the Diskhaler®, Diskus® and metered-dose inhaler in healthy volunteersBRINDLEY, Charles; FALCOZ, Christine; MACKIE, Alison E et al.Clinical pharmacokinetics. 2000, Vol 39, pp 1-8, issn 0312-5963, SUP1Article

Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler® and Diskus® powder devices in healthy volunteersMACKIE, Alison E; MCDOWALL, Jo E; FALCOZ, Christine et al.Clinical pharmacokinetics. 2000, Vol 39, pp 23-30, issn 0312-5963, SUP1Article

Protein stability in pulmonary delivery formulations : A reviewKRISHNAMURTHY, R.Pharmaceutical technology. 1999, Vol 23, Num 3, pp 48-60, issn 0147-8087, 7 p.Article

The role of fine particle lactose on the dispersion and deaggregation of salbutamol sulphate in an air stream in vitroXIAN MING ZENG; MARTIN, G. P; TEE, S.-K et al.International journal of pharmaceutics. 1998, Vol 176, Num 1, pp 99-110, issn 0378-5173Article

Influence of the moisture on the performance of a new dry powder inhalerMAGGI, L; BRUNI, R; CONTE, U et al.International journal of pharmaceutics. 1999, Vol 177, Num 1, pp 83-91, issn 0378-5173Article

An easy-to-use dry-powder inhalerKARPEL, Jill P.Advances in therapy. 2000, Vol 17, Num 6, pp 282-286, issn 0741-238XArticle

Application of spectrofluorometry for evaluation of dry powder inhalers in vitroSRICHANA, T; SUEDEE, R; SRISUDJAI, P et al.Pharmazie. 2003, Vol 58, Num 2, pp 125-129, issn 0031-7144, 5 p.Article

In vitro deposition of the respirable fraction of dry powder inhalations determined by laser diffractometry and inertial impactionCABRAL MARQUES, H. M; SCHMIDT, P. C.Pharmazie. 2002, Vol 57, Num 8, pp 546-551, issn 0031-7144Article

Quantification of the surface morphologies of lactose carriers and their effect on the in vitro deposition of salbutamol sulphateHENG, P. W. S; CHAN, L. W; LIM, L. T et al.Chemical and pharmaceutical bulletin. 2000, Vol 48, Num 3, pp 393-398, issn 0009-2363Article

Design of inhalation dry powder of pranlukast hydrate to improve dispersibility by the surface modification with light anhydrous silicic acid (AEROSIL 200)KAWASHIMA, Y; SERIGANO, T; HINO, T et al.International journal of pharmaceutics. 1998, Vol 173, Num 1-2, pp 243-251, issn 0378-5173Article

Efficacy and tolerability of beclomethasone dipropionate delivered by a novel multidose Dry powder inhaler (Clickhaler®) versus a metered-dose inhaler in children with asthmaADLER, L. Martin; ANAND, Chaman; BUCK, Helen et al.Current therapeutic research. 2001, Vol 62, Num 11, pp 758-769, issn 0011-393XArticle

Once-daily inhaled corticosteroids in children with asthma: Dry powder inhalersMÖLLER, C.Drugs (Basel). 1999, Vol 58, pp 35-41, issn 0012-6667, SUP4Article

High-performance liquid chromatography of lactose with evaporative light scattering detection, applied to determine fine particle dose of carrier in dry powder inhalation productsBEILMANN, Bianca; LANGGUTH, Peter; HÄUSLER, Heribert et al.Journal of chromatography. 2006, Vol 1107, Num 1-2, pp 204-207, issn 0021-9673, 4 p.Article

Jahrestagung der Deutschen Pharmazeutischen Gesellschaft e.V., Bilanz 2000, 4.-7. October 2000, Münster, Kurzfassungen zu den BeiträgenArchiv der Pharmazie (Weinheim). 2000, Vol 333, issn 0365-6233, 84 p., SUP2Conference Proceedings

Modification of electrostatic charge on inhaled carrier lactose particles by addition of fine particlesBENNETT, F. S; CARTER, P. A; ROWLEY, G et al.Drug development and industrial pharmacy. 1999, Vol 25, Num 1, pp 99-103, issn 0363-9045Article

Effect of mannitol crystallization on the stability and aerosol performance of a spray-dried pharmaceutical protein, recombinant humanized anti-IgE monoclonal antibodyCOSTANTINO, H. R; ANDYA, J. D; NGUYEN, P.-A et al.Journal of pharmaceutical sciences. 1998, Vol 87, Num 11, pp 1406-1411, issn 0022-3549Conference Paper

Equivalent clinical effectiveness of old and new models of EasyhalerNIEMINEN, M. M; AHONEN, A; LAURIKAINEN, K et al.Current therapeutic research. 1999, Vol 60, Num 2, pp 73-80, issn 0011-393XArticle

Formoterol as dry powder oral inhalation compared with salbutamol metered-dose inhaler in acute exacerbations of chronic obstructive pulmonary diseaseCAZZOLA, M; D'AMATO, M; CALIFANO, C et al.Clinical therapeutics. 2002, Vol 24, Num 4, pp 595-604, issn 0149-2918Article

Effect of surface morphology of carrier lactose on dry powder inhalation property of pranlukast hydrateKAWASHIMA, Y; SERIGANO, T; HINO, T et al.International journal of pharmaceutics. 1998, Vol 172, Num 1-2, pp 179-188, issn 0378-5173Article

Poly(L-lactic acid) microspheres for pulmonary drug delivery : release kinetics and aerosolization studiesEL-BASEIR, M. M; KELLAWAY, I. W.International journal of pharmaceutics. 1998, Vol 175, Num 2, pp 135-145, issn 0378-5173Article

Effect of surface covering of lactose carrier particles on dry powder inhalation properties of salbutamol sulfateIIDA, Kotaro; HAYAKAWA, Youhei; OKAMOTO, Hirokazu et al.Chemical and pharmaceutical bulletin. 2003, Vol 51, Num 12, pp 1455-1457, issn 0009-2363, 3 p.Article

Influence of low temperature on bronchodilatation induced by terbutaline administered by metered dose or dry powder inhalers in asthmaticsRAMON, M; JUAN, G; CISCAR, M. A et al.Fundamental & clinical pharmacology. 2000, Vol 14, Num 2, pp 133-138, issn 0767-3981Conference Paper

SENSITIVE LC METHOD FOR SIMULTANEOUS DETERMINATION OF CICLESONIDE AND FORMOTEROL FUMARATE IN DRY POWDER INHALERPATIL, Ashish T; PATIL, Sachin D; SHAIKH, Kabeer A et al.Journal of liquid chromatography & related technologies. 2011, Vol 34, Num 13-16, pp 1568-1577, issn 1082-6076, 10 p.Article

A study comparing the clinical pharmacokinetics, pharmacodynamics, and tolerability of triamcinolone acetonide HFA-134a metered-dose inhaler and budesonide dry-powder inhaler following Inhalation administrationARGENTI, D; SHAH, B; HEALD, D et al.Journal of clinical pharmacology. 2000, Vol 40, Num 5, pp 516-526, issn 0091-2700Conference Paper